SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Tempus ECG-AF
AI Verdict
Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…
Choose SensiCardiac Mobi if your primary need is to quickly and accurately differentiate between physiological and pathological heart murmurs during a patient's physical examination. This tool is ideal for clinicians across specialties, including pediatrics, who require AI-powered decision support to analyze acoustic heart signals in real-time and guide further diagnostic steps.
View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your goal is to proactively identify older adult patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year, utilizing their standard 12-lead ECG data. This solution is best suited for integrating into existing cardiology workflows to flag high-risk individuals for earlier follow-up and preventative management, rather than immediate diagnostic assessment of existing symptoms.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Hosted server environment (Linux OS) with a mobile application interface | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATIONTool A, SensiCardiac Mobi, offers a mobile application interface for real-time heart sound analysis at the point of care, requiring only a compatible electronic stethoscope. This direct, interactive approach on a mobile device likely provides a more immediate and hands-on user experience for clinicians during patient examinations compared to Tool B's system integration.
Clinical Value
TieBoth tools offer significant clinical value, are FDA-cleared, and address critical areas in cardiology. Tool A aids in the immediate diagnosis of heart murmurs, a common clinical challenge, while Tool B provides predictive risk assessment for Atrial Fibrillation, a serious condition, leveraging a large training dataset. Their value propositions are strong but target different clinical needs and workflows.
Pricing & Value
Tempus ECG-AFTool B, Tempus ECG-AF, clearly outlines CMS reimbursement availability with specific CPT codes and a Medicare rate, which significantly enhances its financial value proposition for healthcare providers. Tool A, SensiCardiac Mobi, only states 'contact for pricing' with no public details or reimbursement information, making its financial value less transparent.
Enterprise Readiness
Tempus ECG-AFBoth tools are HIPAA compliant and have BAAs, indicating a foundational readiness for enterprise use. However, Tool B explicitly states it is a 'software solution, integrated into healthcare facility systems,' suggesting a more robust and seamless enterprise-level deployment strategy compared to Tool A's 'hosted server environment' with a mobile application interface, which might imply a more departmental or standalone implementation.
Innovation
SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATIONTool A, SensiCardiac Mobi, demonstrates a higher degree of innovation by applying AI to real-time acoustic heart signal analysis via a mobile application and electronic stethoscope, bringing advanced diagnostics directly to the point of care for a traditional diagnostic method. While Tool B's predictive analytics for AF risk from standard ECGs is valuable, the integration of AI with mobile auscultation feels more novel in its approach to clinical practice.
Support & Docs
TieNeither the provided structured facts nor general web searches yielded specific, comparable information regarding the availability, quality, or scope of support and documentation for either SensiCardiac Mobi or Tempus ECG-AF. Without this crucial information, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Tempus ECG-AF |
|---|---|---|
| Tool Name | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Tempus ECG-AF |
| Company | DIACOUSTIC MEDICAL DEVICES (PTY) | Tempus AI, Inc. |
| Description | FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Key Functionality | Analyzes acoustic heart signals to differentiate between physiological and pathological heart murmurs. | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Target Patient Population | Not specified | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| Required Hardware/Input | Compatible electronic stethoscope (user-provided), Mobile application for data capture and display (e.g., iPhone 4S or later) | FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems |
Videos
Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Tempus ECG-AF.
Frequently Asked Questions
More Comparisons
More matchups featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION or Tempus ECG-AF
Backers
Who funded each tool's parent company.